pharma news today obesity drugs glp-1 october 2025 health Outlook for obesity in 2025: more Anti-Obesity Drug Market Outlook 2025–2032:
Description
Learn about tirzepatide side effects anxiety, including symptoms, causes, and when to seek care.
It caused tumors in animal studies
Includes Repatha side effects, indications, and FDA approvals.
The poll finds 12% of adults report having taken one of these GLP-1 drugs, which include Ozempic, Webovy and Mounjaro
However, there may be unappreciated benefits of this combination of therapies
